Hemab Therapeutics Holdings, Inc.
COAG
$54.94
$0.991.84%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -6.45% | 20.23% | |||
| Total Depreciation and Amortization | 2.74% | 2.67% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 30.69% | -200.65% | |||
| Change in Net Operating Assets | 55.20% | -269.99% | |||
| Cash from Operations | -4.88% | -17.65% | |||
| Capital Expenditure | 79.46% | 100.00% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -582.64% | 459.69% | |||
| Cash from Investing | -577.96% | 458.73% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | 100.00% | -3.45% | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 200.00% | -- | |||
| Cash from Financing | 69,138.91% | -3.45% | |||
| Foreign Exchange rate Adjustments | 100.45% | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 591.96% | 132.22% | |||